Get the Stockscreener App
13.55
128.69%
7.6249
After Hours:
12.95
-0.60
-4.43%
Forte Biosciences Inc stock is traded at $13.55, with a volume of 29.52M.
It is up +128.69% in the last 24 hours and up +186.47% over the past month.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).
See More
Previous Close:
$5.9251
Open:
$10.46
24h Volume:
29.52M
Relative Volume:
64.32
Market Cap:
$22.03M
Revenue:
-
Net Income/Loss:
$-31.48M
P/E Ratio:
-11.68
EPS:
-1.16
Net Cash Flow:
$-28.71M
1W Performance:
+138.98%
1M Performance:
+186.47%
6M Performance:
-10.72%
1Y Performance:
+11.16%
1-Day Range:
$8.7914
$18.81
1-Week Range:
$5.3821
$18.81
52-Week Range:
$4.11
$21.25
Forte Biosciences Inc Stock (FBRX) Company Profile
Name
Forte Biosciences Inc
Sector
Industry
Phone
(310) 618-6994
Address
3060 PEGASUS PARK DRIVE, DALLAS, CA
Compare FBRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| FBRX | 13.55 | 22.03M | 0 | -31.48M | -28.71M | -1.16 |
| VRTX | 451.23 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 743.35 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 591.82 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 248.79 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 102.14 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Forte Biosciences Inc Stock (FBRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-20-21 | Upgrade | Chardan Capital Markets | Sell → Buy |
| Sep-03-21 | Downgrade | B. Riley Securities | Buy → Neutral |
| Sep-03-21 | Downgrade | Chardan Capital Markets | Buy → Sell |
| Sep-03-21 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Sep-03-21 | Downgrade | Truist | Buy → Hold |
| May-14-21 | Initiated | B. Riley Securities | Buy |
| Mar-26-21 | Initiated | Citigroup | Buy |
| Aug-28-20 | Upgrade | Chardan Capital Markets | Neutral → Buy |
| Aug-25-20 | Initiated | Truist | Buy |
View All
Forte Biosciences Inc Stock (FBRX) Latest News
Forte Biosciences Secures $53M for FB102 Advancements - TipRanks
Artelo Biosciences (ARTL) Stock Surges Amid Strong Buy Ratings - GuruFocus.com
EDIT Stock Drops Amid Market Volatility in Biotech Sector - GuruFocus.com
Lexicon Pharmaceuticals (LXRX) Stock Plummets Amidst Market Acti - GuruFocus.com
Forte Biosciences Shares Are Soaring Today: What's Going On? - Benzinga
Crude Oil Moves Lower; Williams-Sonoma Shares Gain After Q3 Results - Benzinga
Forte Biosciences secures $53 million in funding - Investing.com India
Forte Biosciences More Than Doubles on $53M Private Placement - MarketWatch
Forte Biosciences Stock More Than Doubles On Oversubscribed $53M Private Placement: Retail Goes Wild - Asianet Newsable
Stock Market News: Forte Biosciences +151.47%, Exicure +99.48% among top gainers during mid day trading - Business Upturn
Stock Market News: Ethan Allen Interiors down by 90.10% while Exicure gains 99.48% during mid day trading - Business Upturn
Nasdaq Tumbles Over 100 Points; TJX Earnings Top Views - Benzinga
Stock Market Today: Forte Biosciences up by 54.60% while Red Cat Holdings gains 35% in early trading - Business Upturn
Stock Market Today: Ethan Allen Interiors falls by nearly 90% while Forte Biosciences surges by 64.89% in early trading - Business Upturn
US Stocks Mostly Lower; Target Posts Downbeat Earnings - Benzinga
Forte Biosciences secures $53 million in funding By Investing.com - Investing.com UK
Thrive Tribe Technologies Affirms ASX Compliance Amid Stock Query - MSN
Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications - The Bakersfield Californian
Forte Biosciences Secures $53M Private Placement for Autoimmune Drug Development | FBRX Stock News - StockTitan
IBD Rating Upgrades: Chesapeake Utilities Flashes Improved Relative Price Strength - MSN
Celiac Disease Pipeline Grows as 25+ Key Pharma Companies Join the Fight for Innovative Treatments | DelveInsight - Lelezard
Forte Biosciences, Inc. announced that it expects to receive $53 million in funding from OrbiMed Advisors LLC, Janus Henderson Group plc, Tybourne Capital Management Limited, Ikarian Capital, LLC, BVF Partners L.P., Fred Alger Management, LLC - Marketscreener.com
When the Price of (FBRX) Talks, People Listen - Stock Traders Daily
Psyence Biomedical gets extension to show compliance with Nasdaq’s listing rules - MSN
Brown Advisory US Smaller Companies PLC Updates Office Location - MSN
Stephens & Co. Initiates Coverage of IDEAYA Biosciences (IDYA) with Overweight Recommendation - MSN
Forte Biosciences (NASDAQ:FBRX) Stock Price Expected to Rise, Chardan Capital Analyst Says - Defense World
Forte Biosciences Inc reports results for the quarter ended September 30Earnings Summary - XM
Perceptive Advisors LLC Acquires Shares in Forte Biosciences Inc - GuruFocus.com
Wolfe Research Initiates Coverage of Bristol-Myers Squibb CompanyPreferred Security (BMYMP) with Peer Perform Recommendation - MSN
Forte Biosciences Inc (FBRX) Quarterly 10-Q Report - Quartz
Forte Biosciences Inc. Reports Q3 2024 Earnings - TipRanks
Tocagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Forte Biosciences Advances Celiac Disease Trial as Q3 Losses Widen to $4.54/Share | FBRX Stock News - StockTitan
Upwork (UPWK) Now Trades Above Golden Cross: Time to Buy? - MSN
Head to Head Analysis: Sycamore Entertainment Group (OTCMKTS:SEGI) & Forte Biosciences (NASDAQ:FBRX) - Defense World
Stock Traders Purchase Large Volume of Call Options on Forte Biosciences (NASDAQ:FBRX) - Defense World
Traders Buy Large Volume of Call Options on Alaska Air Group (NYSE:ALK) - Defense World
Avadel Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:AVDL) - Defense World
Wendy’s Target of Unusually High Options Trading (NASDAQ:WEN) - Defense World
Traders Buy High Volume of Call Options on Guidewire Software (NYSE:GWRE) - Defense World
Patterson-UTI Energy Sees Unusually Large Options Volume (NASDAQ:PTEN) - Defense World
SIGA Technologies Target of Unusually High Options Trading (NASDAQ:SIGA) - Defense World
Stock Traders Buy Large Volume of Call Options on Etsy (NASDAQ:ETSY) - Defense World
Sunnova Energy International Target of Unusually High Options Trading (NYSE:NOVA) - Defense World
FBRX stock touches 52-week low at $4.41 amid market challenges - Investing.com India
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.39% - MSN
Bright Minds Bio soars on US$35M private placement; up 5,400% in 5 days - Mugglehead
CSG Forte Engage Honored for Innovation in Top Industry Awards - Yahoo Finance
Organic Propolis Market Report Analysis, Research Studies |Forté Pharma, Propolia, HoneyGreen, Parchem, Bee Health, Vond – IndiaPolitics.com - IndiaPolitics.com
FBRX stock touches 52-week low at $4.8 amid market challenges - Investing.com Australia
Forte Biosciences Inc Stock (FBRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.69%
6.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):